BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kube T, Hofmann VE, Glombiewski JA, Kirsch I. Providing open-label placebos remotely-A randomized controlled trial in allergic rhinitis. PLoS One 2021;16:e0248367. [PMID: 33705475 DOI: 10.1371/journal.pone.0248367] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Buergler S, Sezer D, Bagge N, Kirsch I, Locher C, Carvalho C, Gaab J. Imaginary pills and open-label placebos can reduce test anxiety by means of placebo mechanisms. Sci Rep 2023;13:2624. [PMID: 36788309 DOI: 10.1038/s41598-023-29624-7] [Reference Citation Analysis]
2 Bräscher AK, Ferti IE, Witthöft M. Open-Label Placebo Effects on Psychological and Physical Well-Being: A Conceptual Replication Study. Clin Psychol Eur 2022;4:e7679. [PMID: 36762351 DOI: 10.32872/cpe.7679] [Reference Citation Analysis]
3 Heiss U, Rosenfield M, Bernstein MH. Can the Open Label Placebo Rationale Be Optimized? Front Pain Res (Lausanne) 2021;2:734882. [PMID: 35295434 DOI: 10.3389/fpain.2021.734882] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Locher C, Buergler S, Frey Nascimento A, Kost L, Blease C, Gaab J. Lay perspectives of the open-label placebo rationale: a qualitative study of participants in an experimental trial. BMJ Open 2021;11:e053346. [PMID: 34408060 DOI: 10.1136/bmjopen-2021-053346] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
5 Kube T, Hofmann VE, Glombiewski JA, Kirsch I. Correction: Providing open-label placebos remotely-A randomized controlled trial in allergic rhinitis. PLoS One 2021;16:e0252850. [PMID: 34077482 DOI: 10.1371/journal.pone.0252850] [Reference Citation Analysis]